Five new mononuclear Pt(II) complexes with 5-perfluoroalkyl-1,2,4-oxadiazolyl-pyridine and 3-perfluoroalkyl-1,2,4-triazolyl-pyridine ligands are reported. The ligands 2-(5-perfluoroheptyl-1,2,4-oxadiazole-3yl)-pyridine
Introduction
In the last decades, the successful application of cisplatin antitumor therapies has triggered considerable interest in the search for more affective cisplatin analogs. Many efforts have been dedicated to explain the factors related to the anticancer activity of cisplatin and different platinum compounds [1, 2] and although the molecular mechanistic studies of cisplatin and analogs have been largely developed, the cellular response to these compounds is still poorly understood [3, 4] .
Several studies have been conducted with common goals, such as the design of new metal complexes that keep active against resistant cell lines, with a large spectrum of anticancer activity and also with a lower toxicity than cisplatin [5] . However, the cross resistance and severe side effects of platinum drugs, such as nephrotoxicity, have limited their clinical application. In the past years, successful approaches have been employed to solve these drawbacks, combining platinum-based drugs with some other active pharmacophore so that a synergic action can be obtained [6] . Oxadiazole and triazole have been recently used for complexation of metal such as copper, nickel [7] , palladium [8] and platinum [9] ; 1,2,4-oxadiazoles have been widely studied for their chemistry [10] [11] [12] , these heterocycles have gained attention for their pharmaceutical properties, and additionally, the presence of the fluorinated moiety opens the way to new fluorine-induced activity with respect to corresponding non-fluorinated systems [13] [14] [15] [16] and application in materials [17] [18] [19] [20] [21] . In particular, a series of Pt(II) complexes with 1,2,4-oxadiazole derivatives as ligands have shown cytotoxic activity towards human ovarian cancer, and also in colon and testicular cancer cell lines. This activity has been attributed to their DNA-binding properties [22] . In the same way, triazole rings have been widely studied as bioactive moieties [23] and also have been used as ligands in order to synthesize cytotoxic platinum, palladium and organotin(IV) complexes [24] [25] [26] [27] .
In this paper, we report the synthesis and characterization of new platinum complexes and the synthesis of the new ligands: pfhop, pfpop, pfhtp and pfptp. In 2a and 3a complexes, the coordination of 2-(5-perfluoroalkyl-1,2,4-oxadiazol-3yl)-pyridine ligands involve the N1 atom of pyridine, acting as monodentate ligand, as already observed in the literature for Cu(II), Co(II) and Ni(II) complexes with 2,5-bis(2-pyridyl)-1,3,4-oxadiazolyl-pyridine [7] . The coordination of Pt(II) ion to the 2-(3-perfluoroalkyl-1-methyl-1,2,4-triazole-5yl)-pyridine ligands for 4a and 5a complexes, occurs via N2 atoms of two 1,2,4-triazole moieties as already observed in the literature for azole-bridged dinuclear platinum(II) complexes [24] . On the contrary, in the case of 4b, only one molecule of 1,2,4-triazolyl-pyridine is coordinated to Pt(II) ion via N4 atom of triazole moiety and N1 atom of pyridine respectively, where the ligand is bidentate as reported in literature with Pt(II) and Pd(II) ions [8] . Cytotoxicity in vitro of the synthesized cisplatin analogs was evaluated by MTT test on three tumor human cell lines: HepG2, MCF-7 and HTC116. The calculated IC 50 values of 2a and 4b complexes show that antiproliferative activity of both the cisplatin analogs was comparable to that observed with cisplatin, being 2a significantly more effective than 4b against all the selected cancer cells. Mechanism of the anti-proliferative effect of 2a and 4b was investigated by double staining with propidium iodide (PI) and Annexin VFluorescein isothiocyanate (FITC) followed by cytofluorimetric analysis and shows that 2a and 4b complexes induce a clear shift of viable cells towards early apoptosis in HepG2 and HCT116 or towards late apoptosis in MCF-7 cells.
Experimental

General methods
All solvents and reagents were obtained from commercial sources (Sigma-Aldrich). Cis-[PtCl 2 (DMSO) 2 ] [28] and N-hydroxypicolinamidine 1 (95% yields, m.p. 116-118°C) were synthesized according to previously reported method [29] . Syntheses were performed with exclusion of moisture and direct light. Elemental analysis for C, H, N, were performed at the Laboratorio di Microanalisi (University of Padova, Italy); chlorine was determined by potentiometric titration with standard silver nitrate after combustion in pure oxygen according to Schöniger [30] . The percentage of platinum in the complexes has been measured by a Perkin-Elmer 372 atomic absorption spectrometer against the appropriate standards. IR spectra (Nujol) were registered with a Shimadzu FTIR-8300 instrument. 1 H NMR spectra were recorded on a Bruker 300 Avance spectrometer, operating at 300 MHz, with tetramethylsilane (TMS) as an internal standard. The molar conductivities for all complexes were determined in DMSO at 10 −3 M at 25°C with a Crison GLP 31 Model Conductometer.
Gas Chromatography/Mass Spectrometry (GC/MS) spectra were determined with a Shimadzu QP-2010 instrument. High Resolution Mass (HRMS) were determined by Agilent Technologies 6540 UHD AccurateMass Q-TOF LC/MS instrument. Melting points were determined on a Kofler plate with Reichart-Thermovar hotstage apparatus and are uncorrected. Flash chromatography was performed by using silica gel (Merck, 0.040-0.063 mm) and mixtures of ethyl acetate and petroleum (fraction boiling in the range 40-60°C) in various ratios.
Synthesis of ligands
2.2.1. General method of synthesis of 1,2,4-oxadiazolyl-pyridines The synthetic approach for the preparation of substituted 1,2,4-oxadiazoles derivatives is shown in Scheme 1. N-hydroxypicolinamidine 1 (1 g) was dissolved in toluene (60 ml) in a round-bottomed flask, and then pyridine (1 ml) and appropriate acyl chloride (1.2 equivalent) were added.
The reaction mixture was allowed to reflux for 6-8 h and was monitored by thin layer chromatography (TLC) until the reaction was complete. The solvent was removed under vacuum, and then the residue was added with water (60 ml) and extracted with ethyl acetate (50 ml × 3). The organic layer was dried over anhydrous Na 2 SO 4 , and solvent was removed under vacuum. The residue was purified through silica gel column chromatography using a mixture of ethyl acetate and petroleum as eluent to afford the desired oxadiazolyl-pyridine [31] [32] .
The compound 2 was prepared following the general procedure, by reacting N-hydroxypicolinamidine 1 (1.015 g, 7.293 mmol) and pentadecafluorooctanoyl chloride (2.170 
2.2.4.
General procedure for the synthesis of 1,2,4-triazoles The synthetic approach for the preparation of substituted 1,2,4-triazoles derivatives is shown in Scheme 1. To a sample of oxadiazolylpyridine (1.5 mmol) in dry dimethylformamide (DMF) (2 ml) an excess of 99% methyl hydrazine (7.5 mmol) was added and the mixture was left at room temperature for 1 h. After dilution with water and extraction with ethyl acetate, the combined extracts were dried over Na 2 SO 4 and the solvent was removed under vacuum. The residue was purified through silica gel column chromatography using a mixture of ethyl acetate and petroleum as eluent to afford the desired triazolyl-pyridine [32] .
Compound 4 was prepared starting by 2-(5-Perfluoroheptyl-1,2,4-oxadiazol-3-yl)-pyridine 2 (1.011 g, 1.963 mmol). The product was extracted with ethyl acetate, purified through silica gel column chromatography using petroleum/ethyl acetate in ratio 6/1, affording a white crystalline solid in 70% yield; m.p. 49-51°C. 1 
Biological studies 2.4.1. Viability assay in vitro
Synthesized platinum(II) complexes and relative ligands were dissolved in dimethylsulfoxide (DMSO) and then diluted in culture medium so that the effective DMSO concentration did not exceed 0.1%. HepG2, MCF-7 and HTC116 and Caco-2 (human colorectal carcinoma) cell lines were purchased from American Type Culture Collection, Rockville, MD, USA. All of them were grown in Roswell Park Memorial Institute (RPMI) medium supplemented with Lglutamine (2 mM), 10% fetal bovine serum (FBS), penicillin (100 U/ml), streptomycin (100 μg/ml) and gentamicin (5 μg/ml). HepG2 culture medium also contained sodium pyruvate (1.0 mM). Cells were maintained in log phase by seeding twice a week at a density of 3 × 10 8 cells/l in humidified 5% CO 2 atmosphere, at 37°C. In all experiments, cells were made quiescent through overnight incubation before the treatment with the compounds or vehicle alone (control cells) whereas Caco-2 cells were treated 15 days after confluence, at which time the cells are differentiated in normal intestinal-like cells [34] . No differences were found between cells treated with DMSO 0.1% and untreated cells in terms of cell number and viability. Cytotoxic activity of the platinum(II) complexes against human tumor cell lines (HepG2, MCF-7 and HCT116) and intestinal-like differentiated cells (Caco2) was determined by the MTT colorimetric assay based on the reduction of 3-(4,5-dimethyl-2-thiazolyl)bromide-2,5-diphenyl-2H-tetrazolium to purple formazan by mitochondrial dehydrogenases of living cells. This method is commonly used to illustrate inhibition of cellular proliferation. Monolayer cultures were treated for 24 h with various concentrations (0.1-100 μM) of the drugs. Cisplatin and ligands were used for comparison. Briefly, all cell lines were seeded at 2 × 10 4 cells/well in 96-well plates containing 200 μl RPMI. When appropriated, cells were washed with fresh medium and incubated with the compounds in RPMI. After 24 h incubation, cells were washed, and 50 μl FBS-free medium containing 5 mg/ml MTT were added. The medium was discarded after 2 h incubation at 37°C by centrifugation, and formazan blue formed in the cells was dissolved in DMSO. The absorbance, measured at 570 nm in a microplate reader (Bio-RAD, Hercules, CA), of MTT formazan of control cells was taken as 100% of viability. IC 50 value for each 
Measurement of phosphatidylserine exposure
The externalization of phosphatidylserine (PS) to the cell surface was detected by flow cytometry by double staining with Annexin V-FITC/PI. Phosphatidylserine, which is normally located on the cytoplasmic surface of cell membranes, is exposed on the cell surface upon induction of apoptosis. Annexin V binds to phosphatidylserine and is used to identify the earliest stage of apoptosis. PI, which does not enter cells with intact membranes, is used to distinguish between early apoptotic cells (Annexin V fluorescence-activated cell sorting (FACS) analysis by Epics XL™ flow cytometer using Expo32 software (Beckman Coulter, Fullerton, CA), using appropriate 2-bidimensional gating method.
2.4.3.
Acridine orange and ethidium bromide morphological fluorescence dye staining AO stains DNA bright green, allowing visualization of the nuclear chromatin pattern and stains both live and dead cells. EB stains DNA orange but is excluded by viable cells. Dual staining allows separate enumeration of populations of viable non apoptotic, viable (early) apoptotic, nonviable (late) apoptotic, and necrotic cells. Live cells appear uniformly green. Early apoptotic cells stain green and contain bright green dots in the nuclei as a consequence of chromatin condensation and nuclear fragmentation. Late apoptotic cells incorporate EB and therefore stain orange, but, in contrast to necrotic cells, the late apoptotic cells show condensed and often fragmented nuclei. Necrotic cells stain orange, but have a nuclear morphology resembling that of viable cells, with no condensed chromatin. Briefly, after tumor cells (HepG2, MCF-7 and HCT116) were treated with the compounds for 24 h, the medium was discarded. Cells were washed with saline 5 mM phosphate buffer (PBS) and then incubated with 100 μl PBS containing 100 μg/ml of EB plus 100 μg/ml of AO. After 20 s, EB/AO solution was discarded and cells immediately visualized by means of fluorescent microscope equipped with an automatic photomicrograph system (Leica, Wetzlar, Germany). Multiple photos were taken at randomly selected areas of the well to ensure that the data obtained are representative.
Results and discussion
IR spectra
The IR spectra of 2, 3, 4 and 5 free ligands show two characteristic bands due to v(CH_N) of pyridine rings at ca. 1590 cm ing that the ligands were present in the complexes; in fact the bands are shifted for complexation of the ligand to the platinum ion [35] . The presences of v(Pt-Cl) at 342 and 326 cm −1 and at 333 e 320 cm −1 in the 2a and 3a complexes respectively, were due to Pt-Cl stretching vibrations. Moreover the observed bands at 279 and 256 cm −1 in 2a and 3a respectively, can be assigned to stretching vibrations of Pt-N bond [36] [37] [38] .
The presence of non-coordinated molecules of solvate DMSO in both 2a and 3a is confirmed by a signal at 1023 cm −1 [38] . The vibration bands v(CH_N) and v(C-F) at ca 1590 cm −1 and at 1242-1147 cm
respectively confirmed the presence of the ligand in 4a, 4b and 5a complexes. The spectra showed also symmetrical and asymmetrical stretching bands of Pt-Cl bond at 338, 312 cm − 1 for 4a, at 343, 320 cm −1 for 4b and at 333, 322 cm −1 for 5a, indicating a cis-square planar arrangement of the platinum(II) via chloride ions; v(Pt-N) vibrations occur at 277, 272 and 271 cm −1 for 4a, 4b and 5a respectively. In the complexes 4a and 5a the ν(S_O) vibrations were present for (solvate) DMSO in the range 1032-1037 cm −1 [39] .
NMR spectra
The coordination mode of the complexes in solution was determined by using the 1 H NMR spectra and the assignments of resonances were based on literature data [40, 9] and are in good agreement with proposed structure. The numbering of protons used for 1 H NMR is shown in Scheme 2. The four proton signals of pyridine coordinated to Pt(II) ion for 2a and 3a complexes are shifted downfield compared to the free ligands. In the ligands, signals are observed in the range 8.79-7.6 ppm for 2a and at 8.85-7.72 ppm for 3a; in the first and second complex doublets are assigned to C 6ʹ H and C 3ʹ H and double of triplet and multiplet to C 5ʹ H and C 4ʹ H respectively. Therefore the coordination of the ligand can be ascribed to the N1 atom of pyridine acting as monodentate, being the proton C 6ʹ H the most shifted, as reported for similar complexes with Mn(II) and Co(II) ions [41] . The presence of a singlet for 2a at 2.65 ppm and for 3a at 2.53 ppm close to the solvent DMSO-d 5 multiplet is attributed to the non-coordinated (solvate) DMSO [39] . The   1 H NMR resonances of 4a, 4b and 5a complexes show a slight shift to down field of pyridine protons as compared to the uncoordinated ligands 4 and 5. The doublet at 8.85 ppm can be attributed to the proton C 6ʹ H for 4a and 4b complexes and it is slightly shifted as compared with the proton C 6ʹ H (8.80 ppm) of the free ligand. Another doublet at 8.22 ppm can be assigned to proton C 5ʹ H, while two triplets for 4a and two doublet of triplets for 4b at 8.11 and 7.68 ppm, can be assigned to C 3ʹ H and C 4ʹ H respectively. The singlet at 4.44 ppm of the methyl group of 1,2,4-triazole is also slightly shifted compared to uncoordinated ligand (4.39 ppm). The presence in 4a of a singlet signal in the range 2.61-2.57 is due to non-coordinated DMSO. Coordination of Pt(II) ion to the ligand for 4a, occurs via N2 atoms of two 1,2,4-triazole moieties and its coordination is completed by PtCl 2 moiety. On the contrary for 4b only one molecule of 1,2,4-triazole is coordinated to Pt(II) ion via N4 atom of triazole and N1 atom of pyridine, where the remaining two coordination sites of the platinum are engaged with two chlorine atoms. Similar complexes with 6-(5-trifluoromethyl-1,2,4-triazol-3yl)-4,4′-dimethyl-2,2′-bipyridine ligand have been reported [42] . In the complex 4a and 5a the coordination environment of Pt(II) ion is equal and the resonance signals of the pyridine protons are not shifted with respect to the ligand and they occur in the range 8.80-7.62 ppm.
Biology
Cytotoxicity in vitro of the synthesized platinum(II) complexes was evaluated by MTT on three tumor human cell lines: HepG2, HTC116 and MCF-7. After 24 h of incubation, a clear dose dependent inhibitory effect of 2a and 4b on the viability of all the studied cancer cell lines was measured, whereas far less cytotoxicity of 3a, 4a and 5a was noticeable (Fig. 1) . Prolonged incubation times (48-72 h) with 2a and 4b resulted in a progressive cell growth inhibition, indicating antiproliferative activity of the compounds (Fig. 2) . Table 1 reports the concentration of 2a and 4b required to inhibit 50% of cell proliferation after 24 h of treatment, when compared to untreated cells (IC 50 ), in comparison with cisplatin assayed in the same experimental conditions. The calculated IC 50 values show that anti-proliferative activity of both the cisplatin analogs was comparable to that observed with cisplatin, being 2a significantly more efficacy than 4b against all the selected cancer cells. Under identical conditions, both the platinum(II) complexes did not substantially impaired viability of intestinal normal-like differentiated Caco-2 cells, suggesting high selectivity towards tumor cells (Fig. 3) . Eventual contribution of the ligand to the cytotoxic activity of 2a and 4b was assessed by MTT after treatment for 24 h of the tumor cell lines with 2 or 4, respectively, at 10 and 100 μM. While 2 did not affect cell viability at any assayed concentration, a slight but significant decrement (P b 0.05) of the cell proliferation of all selected tumor lines was measured with compound 4 at 100 μM ( Table 2) . Mechanism of the anti-proliferative effect (necrosis or apoptosis) of 2a and 4b was investigated by double staining with PI and Annexin V-FITC followed by cytofluorimetric analysis. The chosen concentrations were selected on the basis that they represented the IC 50 values measured at 24 h for each cell line, as reported in Table 1 . Fig. 4 shows that both the compounds did not exert necrotic effects in any cancer cell line, while induced a clear shift of viable cells towards early apoptosis in HepG2 and HCT116 or towards late apoptosis in MCF-7 cells. To confirm apoptotic mechanism of cytotoxicity of the studied platinum(II) complexes, we carried out morphological evaluation of the HepG2, HCT116 and MCF-7 tumor cells using AO and EB double staining. After 24 h of treatment with 2a or 4b at IC 50 concentration, fluorescent microscopy revealed the appearance of cells containing bright green patches in the nuclei as a consequence of chromatin condensation and nuclear fragmentation, which are typical features of apoptosis. Moreover, fluorescing orange cells owing to increase of cell permeability to ethidium bromide, cell shrinkage and nuclear fragmentation were also evident as cells in late apoptosis, chiefly in MCF-7 cell line (Fig. 5) . Taken together, these findings provided strong evidence that both the cisplatin analogs induced apoptosis in the studied tumor cell lines.
Conclusions
The ligands 5-perfluoroalkyl-1,2,4-oxadiazole and 3-perfluoroalkyl-1,2,4-triazole and their metal complexes 2a, 3a, 4a, 4b, 5a with Pt(II) ion have been synthesized and characterized by the combination of elemental analysis, atomic absorption spectrometer, 1 H NMR, IR, and molar conductivities. In the complexes 2a and 3a, the ligands 5-perfluoroalkyl-1,2,4-oxadiazole bind to Pt(II) ion in a monodentate way through the pyridine ring where the geometry of metal is square planar. In 4a and 5a the 3-perfluoroalkyl-1,2,4-triazole ligands also act as monodentate to Pt(II) ion through N2 atom of the 1,2,4-triazole ring. Instead, in 4b the coordination of the ligand to the metal ion occurs in a bidentate mode. The five new complexes and their new ligands synthesized have been tested in vitro. The complexes 2a and 4b and only one ligand 2 were found to be active towards the engaged three tumor cell lines, but 2a was found to be much more active than its ligand 2. A tentative examination of a qualitative structure-activity relationship indicates that the biological activity of the new family of Pt(II) complexes depends on the length of the perfluoroalkyl chain; in fact, the most active complexes are those with pfhop and pfhtp ligands; this fact could be ascribed to an enhanced lipophilicity of the longest perfluoroalkyl chain that could affect the cell membrane permeation. The geometry of Pt(II) is square-planar and the planarity of the complexes was suggested to be essential for antitumor activity, and probable intercalation with DNA [43] ; this fact could suggest an explanation for the lack of bioactivity of complexes 4a and 5a, that being more hindered, twist the planarity of the complex. Furthermore, the complex 4b with respect to 4a has only one ligand moiety, so that around Pt(II) ion there is less steric hindrance, therefore 4b is more available to the formation of DNA binding.
